The 8 analysts offering 1 year price forecasts for ASTH have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to ASTH in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ASTH EPS for the last quarter is 0.33 USD despite the estimation of 0.31 USD. In the next quarter EPS is expected to reach 0.12 USD. Track more of Astrana Health Inc. financials and stay on top of what is up with the company.
In the next quarter Astrana Health Inc. revenue is expected to reach 580.70 M USD. Check out Astrana Health Inc. revenue and earnings and make informed decisions.
According to analysts, ASTH price target is 67.25 USD with a max estimate of 86.00 USD and a min estimate of 55.00 USD. Check if this forecast comes true in a year, meanwhile watch Astrana Health Inc. stock price chart and keep track of the current situation with ASTH news and stock market news.
We've gathered opinions of 10 analysts rating ASTH stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.